The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy
Abstract
We evaluated the immunogenicity and efficacy of hepatitis B vaccine (Heptavax-B) in a randomized, double-blind, placebo-controlled trial involving 1311 patients receiving hemodialysis in the United States. After three doses of vaccine (40 micrograms each) had been administered, 63 per cent of the patients were antibody-positive. After correction for possible passive transfer of antibodies by blood transfusion, only 50 per cent of vaccine recipients were considered vaccine responders. The incidence of hepatitis B viral infection during the 25 months of the trial was much lower than had been anticipated and was virtually the same in the vaccine and placebo recipients (6.4 and 5.4 per cent, respectively). Four cases of hepatitis B occurred in patients who had an apparent antibody response to the vaccine, but in each case either antibody had reached low or undetectable levels before hepatitis B surface antigen was detected or the patient had been receiving immunosuppressive therapy. This study did not demonstrate the efficacy of the vaccine in a population of patients receiving dialysis in whom both the rate of antibody response to hepatitis B vaccine and the viral attack rate were low. Other measures to control transmission of hepatitis B virus in dialysis units, including surveillance for hepatitis B surface antigen and isolation of patients who are positive for the antigen, must be continued.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freiman, J. A., Chalmers, T. C., Smith, H., & Kuebler, R. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197809282991304 · Cited by 1,628
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
Self-citationFRANCIS, D. P., HADLER, S. C., THOMPSON, S. E., MAYNARD, J. E., OSTROW, D. G., ALTMAN, N., BRAFF, E. H., O'MALLEY, P., HAWKINS, D., JUDSON, F. N., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-362 · Cited by 428
Rothman, J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812142992410 · Cited by 303
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units: Efficacy and Subtype Cross-Protection
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Alter, H. J., Taylor, P. E., DE Vera, A., Chen, G. T. S., Kellner, A., & the Dialysis Vaccine Trial Study Group (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072403 · Cited by 262
Self-citationCrosnier, J., Jungers, P., Couroucé, A., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., & Guesry, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92679-9 · Cited by 214
Crosnier, J., Jungers, P., Couroucé, A.-M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., & Guesry, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91847-x · Cited by 163
HEPATITIS B VACCINE: IMMUNE RESPONSES IN HAEMODIALYSIS PATIENTS
Stevens, C., Goodman, A. I., Szmuness, W., Weseley, S. A., & Fotino, M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92477-0 · Cited by 130
Self-citation
Cited by
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., et al. (1989) · Science · doi:10.1126/science.2496467 · Cited by 3,346
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
(2005) · PsycEXTRA Dataset · doi:10.1037/e548682006-001 · Cited by 753
Risks of chronicity following acute hepatitis B virus infection: a review.
Hyams, K. C. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.992 · Cited by 521
Danziger‐Isakov, L., Kumar, D., & Practice, T. A. I. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13563 · Cited by 492
Metadata
- Authors
- Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-08-23
- Volume
- 311
- Issue
- 8
- Pages
- 496-501
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2056524016
- Cited by
- 457
- References
- 8
- FWCI
- 25.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy. https://app.cochat.ai/papers/10.1056/nejm198408233110803
- The paper
- Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group. (1984). Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy. New England Journal of Medicine. https://doi.org/10.1056/nejm198408233110803
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.